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OBJECTIVE — Fewprospectivedataexistontheriskofdiabetesinindividualsservinginthe
U.S. military. The objectives of this study were to determine whether military deployment,
combat exposures, and mental health conditions were related to the risk of newly reported
diabetes over 3 years.
RESEARCH DESIGN AND METHODS — Data were from Millennium Cohort Study
participants who completed baseline (July 2001–June 2003) and follow-up (June 2004–
February2006)questionnaires(follow-upresponserate71.4%).Afterexclusioncriteriawere
applied, adjusted analyses included 44,754 participants (median age 36 years, range 18–68
years). Survey instruments collected demographics, height, weight, lifestyle, military service,
clinician-diagnoseddiabetes,andotherphysicalandmentalhealthconditions.Deploymentwas
deﬁned by U.S. Department of Defense databases, and combat exposure was assessed by self-
report at follow-up. Odds of newly reported diabetes were estimated using logistic regression
analysis.
RESULTS — Occurrence of diabetes during follow-up was 3 per 1,000 person-years. Indi-
viduals reporting diabetes at follow-up were signiﬁcantly older, had greater baseline BMI, and
were less likely to be Caucasian. After adjustment for age, sex, BMI, education, race/ethnicity,
military service characteristics, and mental health conditions, only baseline posttraumatic stress
disorder (PTSD) was signiﬁcantly associated with risk of diabetes (odds ratio 2.07 [95% CI
1.31–3.29]). Deployments since September 2001 were not signiﬁcantly related to higher diabe-
tes risk, with or without combat exposure.
CONCLUSIONS — Inthismilitarycohort,PTSDsymptomsatbaselinebutnotothermental
health symptoms or military deployment experience were signiﬁcantly associated with future
risk of self-reported diabetes.
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T
he risk of type 2 diabetes continues
to increase worldwide, and multiple
risk factors for this condition have
been identiﬁed. Few studies, though,
have assessed risk in a younger working
population or focused on U.S. military
servicemembers,arelativelyhealthypop-
ulation that experiences unique occupa-
tional exposures, including military
deployments. Furthermore, this popula-
tion is at higher risk for psychiatric
disorders such as depression and post-
traumatic stress disorder (PTSD) (1,2)
thatmayalsoberelatedtohigherdiabetes
risk. Studies have reported an increase in
risk of diabetes associated with depression
(2,3), and cross-sectional studies have re-
ported an association between PTSD and
diabetes (4), although it is not possible
without a prospective design to establish
whether PTSD preceded or followed its de-
velopment. Potential mechanisms linking
depression and PTSD to diabetes might in-
volve the stress response associated with
these conditions contributing to inﬂamma-
tion and insulin resistance (5).
We examined the incidence of and
risk factors for diabetes among U.S.
service members participating in the
Millennium Cohort Study, an ongoing
prospective investigation of health out-
comes associated with military service.
We focused on unique exposures in this
populationrelatedtodeploymentandthe
presence of mental health conditions as
potential predictors for the development
of new-onset diabetes in this cohort.
RESEARCH DESIGN AND
METHODS— The Millennium Co-
hort Study enrolled its ﬁrst panel of par-
ticipants between July 2001 and June
2003. Those initially invited comprised
an 11.3% stratiﬁed random sample of the
2.2 million men and women in service as
of 1 October 2000. A total of 77,047 in-
dividuals completed the baseline survey,
representing 36% of invited personnel.
Duringtheﬁrstfollow-upsurveybetween
June 2004 and February 2006, 55,021
(71.4%) individuals completed the fol-
low-up survey questionnaire.
The primary data for these analyses
derive from self-administered surveys
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care.diabetesjournals.org DIABETES CARE, VOLUME 33, NUMBER 8, AUGUST 2010 1771Table 1—Baseline characteristics among nondiabetic individuals by presence of new-onset diabetes at follow-up
No Yes Unadjusted OR (95% CI)* P value
n 44,378 376
Sex
Male 31,895 (73.6) 264 (72.3) 1.00 0.7082
Female 11,450 (26.4) 101 (27.7) 1.04 (0.83–1.31)
Race/ethnicity
Caucasian 31,127 (71.8) 238 (65.2) 1.00 0.0006
African American 5,042 (11.6) 69 (18.9) 1.81 (1.39–2.36)
Hispanic 2,493 (5.8) 23 (6.3) 1.29 (0.85–1.95)
Asian 3,748 (8.6) 27 (7.4) 1.03 (0.70–1.50)
Other 935 (2.2) 8 (2.2) 1.10 (0.54–2.23)
Education
No high school diploma 2,236 (5.2) 19 (5.2) 1.00 0.0400
High school diploma/equivalent 16,292 (37.6) 141 (38.6) 1.04 (0.65–1.69)
Some college 11,497 (26.5) 118 (32.3) 1.26 (0.77–2.04)
Bachelor’s degree 8,343 (19.2) 56 (15.3) 0.80 (0.47–1.35)
Master’s/postdoctoral degree 4,977 (11.5) 31 (8.5) 0.83 (0.47–1.46)
Continuous demographic variables
Age (years) at baseline submission 36.3  8.9 41.7  10.3 1.07 (1.05–1.08) .0001
BMI 26.0  3.3 28.8  3.9 1.22 (1.19–1.25) .0001
Deployment before 2001
No previous deployments 26,896 (62.1) 239 (65.5) 1.00 0.6983
1991 Gulf War only 3,428 (7.9) 29 (7.9) 0.97 (0.66–1.42)
Bosnia/Kosovo/Southwest Asia only 10,797 (24.9) 78 (21.4) 0.87 (0.68–1.11)
Both contingencies 2,224 (5.1) 19 (5.2) 1.06 (0.67–1.65)
Deployment to OEF/OIF before baseline
No 41,716 (96.2) 356 (97.5) 1.00 0.3902
Yes 1,629 (3.8) 9 (2.5) 0.77 (0.42–1.40)
Deployed to OEF/OIF between baseline and
follow-up
Nondeployed 33,624 (77.6) 310 (84.9) 1.00 0.0038
Deployed without combat exposures 4,908 (11.3) 24 (6.6) 0.54 (0.36–0.81)
Deployed with combat exposures 4,813 (11.1) 31 (8.5) 0.72 (0.50–1.03)
Number of deployments between baseline
and follow-up
0 33,624 (77.6) 310 (84.9) 1.00 0.0055
1 4,639 (10.7) 31 (8.5) 0.77 (0.54–1.10)
2 2,965 (6.8) 11 (3.0) 0.39 (0.21–0.72)
3 2,117 (4.9) 13 (3.6) 0.65 (0.37–1.14)
Separated from military as of follow-up
No 37,504 (86.5) 273 (74.8) 1.00 .0001
Yes 5,841 (13.5) 92 (25.2) 2.20 (1.74–2.78)
Branch of service
Army 19,980 (46.1) 183 (50.1) 1.00 0.0685
Navy/Coast Guard 8,177 (18.9) 79 (21.6) 1.05 (0.81–1.36)
Marines 1,843 (4.3) 8 (2.2) 0.52 (0.27–1.03)
Air Force 13,345 (30.8) 95 (26.0) 0.80 (0.63–1.03)
Component
Reserve/Guard 19,214 (44.3) 202 (55.3) 1.00 .0001
Active duty 24,131 (55.7) 163 (44.7) 0.65 (0.53–0.79)
Alcohol consumption
None 23,129 (53.4) 235 (64.4) 1.00 0.0007
Problem drinking only 297 (0.7) 1 (0.3) 0.64 (0.16–2.60)
Binge drinking only 15,505 (35.8) 99 (27.1) 0.63 (0.50–0.80)
Both of the above 4,414 (10.2) 30 (8.2) 0.68 (0.47–0.99)
(continued)
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databases. The Naval Health Research
Center conducted the survey indepen-
dent of the service member’s local com-
mand by contacting the study participant
directlythroughpostalmailore-mailand
not sharing results with the participant’s
local command. Information collected in
thesurveysincludedoccurrenceofdiabe-
tes, cigarette smoking, alcohol consump-
tion, symptoms of depression, panic, and
anxiety (via the Patient Health Question-
naire [PHQ]) (6), weight, height, and
PTSDsymptoms(viathePTSDChecklist-
CivilianVersion[PCL-C])(7).ThePCL-C
is a 17-item self-report rating of PTSD
symptoms during the past 30 days on a
5-point Likert scale, ranging from 1 (not
at all) to 5 (extremely). PTSD symptoms
at baseline were deﬁned as a report of a
moderate or higher level of at least one
intrusion symptom, three avoidance
symptoms, and two hyperarousal symp-
toms(criteriaestablishedbyDSM-IV)(8).
Other anxiety (6 items) and panic (15
items) symptoms were assessed with the
PHQ instrument. Self-reported depres-
sion symptoms (9 items) were assessed
using the PHQ (sensitivity  0.93; spec-
iﬁcity  0.89) and correspond to the de-
pression diagnosis based on the DSM-IV
(9). Symptoms of depression at baseline
were deﬁned as 1) endorsement of de-
pressed mood or anhedonia and 2) re-
sponse of “more than half the days” or
“nearly every day” to at least 5 of the 9
items. Problem drinking was deﬁned as a
positive response on 1 of 5 PHQ items
pertaining to functional impairment due
to alcohol or having received medical ad-
vice to cut down on drinking. Binge
drinking was deﬁned as consuming 5
drinks for men or 4 for women on at
least 1 day in the past year. Nonsmokers
weredeﬁnedasnothavingsmoked100
cigarettesintheirlifetime,pastsmokersas
havingsmoked100cigarettesbutnotat
baseline, and current smokers had
smoked 100 cigarettes and were ac-
tively smoking at baseline. BMI was cal-
culated from self-reported data as weight
in kilograms divided by the square of
height in meters (2).
The DoD Manpower Data Center in
Seaside, California, provided information
on demographic and occupational infor-
mation as of 1 October 2000, when the
sample was pulled, including sex, birth
year,educationallevel,maritalstatus,pay
grade (enlisted or ofﬁcer), race/ethnicity,
service component (active duty or Re-
serve/Guard), service branch (Army, Air
Force, Navy/Coast Guard, or Marine
Corps), service occupation, and deploy-
ment experience in support of Operation
Enduring Freedom/Operation Iraqi Free-
dom(OEF/OIF)between2001and2004.
We further categorized deployment sta-
tusasdeployedwithcombatexposureifa
subject self-reported at least one combat
experience in the past 3 years, including
witnessing death, trauma, prisoners of
war, or refugees.
Outcomes
Occurrence of self-reported diabetes at
follow-upwasassessedwiththefollowing
question“Inthelast3years,hasyourdoc-
tor or other health care professional told
you that you have any of the following
conditions?” [A list of medical conditions
followed that included “Diabetes or sugar
diabetes (Yes/No).”] The aim of this anal-
ysis was to identify risk factors for type 2
diabetes. Therefore, DoD medical record
databases were used to identify and ex-
clude individuals who developed type 1
diabetes during follow-up as reﬂected by
the appearance of ICD-CM codes 250.x1
or 250.x3. Survey data rather than medi-
cal encounter data were used as our pri-
mary sources for capturing new-onset
diabetesbecausemembersoftheReserves
andNationalGuarddonotgenerallyhave
access to the DoD health care system be-
tween periods of activation. Thus, in-
stances of medical care and diagnoses
may not be captured by a review of these
databases.
Statistical analysis
Wecomparedbaselinecharacteristicsand
deployment of study subjects by the oc-
currence of self-reported diabetes at fol-
low-up. Logistic regression analysis to
estimate odds ratios (ORs), 95% CIs, and
P values was conducted. Characteristics
from Table 1 were then separately exam-
ined in logistic models that adjusted for
known risk factors for diabetes available
from the survey or DoD databases (age,
sex, ethnicity, educational attainment,
and BMI) (Table 2). A ﬁnal multivariable
model was developed using age, sex, eth-
nicity, educational attainment, and BMI;
in addition, backward stepwise regres-
sion was used that initially included all
Table 1—Continued
No Yes Unadjusted OR (95% CI)* P value
Smoking status
Nonsmoker 25,862 (59.7) 208 (57.0) 1.00 0.6771
Past smoker 10,898 (25.1) 102 (27.9) 1.11 (0.88–1.40)
Current smoker 6,585 (15.2) 55 (15.1) 1.00 (0.75–1.35)
Major depressive disorder
No 42,209 (97.4) 347 (95.1) 1.00 0.0047
Yes 1,136 (2.6) 18 (4.9) 1.95 (1.23–3.11)
Panic disorder
No 42,898 (99.0) 353 (96.7) 1.00 .0001
Yes 447 (1.0) 12 (3.3) 3.19 (1.78–5.71)
Anxiety disorder
No 42,594 (98.3) 353 (96.7) 1.00 0.0130
Yes 751 (1.7) 12 (3.3) 2.03 (1.16–3.54)
PTSD
No 41,781 (96.4) 334 (91.5) 1.00 .0001
Yes 1,564 (3.6) 31 (8.5) 2.56 (1.78–3.67)
Data are n (%) or mean  SD. N  44,754. *Bold values indicate statistical signiﬁcance at P  0.05.
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weresigniﬁcantatP0.10(Table3).We
assessed the presence of interaction be-
tweeneachpsychiatricconditionwithsex
and separation from service (separation
assessed at follow-up). Variables were re-
tained in the ﬁnal model if P  0.10 be-
fore the inclusion of interaction terms.
Regression diagnostics included examining
covariates for multicollinearity. We con-
ducted all data analyses using SAS software
(version 9.1.3; SAS Institute, Cary, NC).
RESULTS— Among the 55,021 sub-
jectswhocompletedthe3-yearfollow-up
survey, exclusions for this analysis were
made for the following reasons: 1 person
withdrew permission to use his or her
data, 454 had missing responses to the
diabetes question at baseline, 722 re-
ported diabetes at baseline, 29 had type 1
diabetes during follow-up, 3,538 had
missing data on any covariate, 3,284 de-
ployed before the baseline survey, and
2,239 had missing diabetes response at
follow-up. Among the 44,754 subjects
available for this analysis, 376 reported
developingdiabeteswithinthe3-yearfol-
low-up period. A univariate comparison
of baseline characteristics by diabetes sta-
tus at follow-up revealed that individuals
who developed diabetes were signiﬁ-
cantly older, had a higher BMI, and were
morelikelytobeAfricanAmerican(Table
1). Certain military service characteristics
differed by whether diabetes developed,
includingseparationfrommilitaryservice
since baseline, deployment without com-
bat exposure, and active duty as opposed
to Reserve/National Guard status (Table
1). Binge and/or problem drinking was
less frequent at baseline among individu-
als who developed diabetes, whereas
symptoms of all four psychiatric condi-
tions were more common (Table 1).
Comparison of baseline characteris-
tics by diabetes occurrence at follow-up
adjustedforage,sex,ethnicity,education,
and BMI reduced the magnitude of the
associations between most exposures and
odds of diabetes (Table 2). Statistically
signiﬁcant associations remained only
with the following exposures: two de-
ploymentssincebaseline,separationfrom
service, panic disorder, other anxiety dis-
order, and PTSD at baseline.
A multivariable model to predict
newly reported diabetes was constructed,
and assessment of interaction was con-
ducted as described previously (Table 3).
Only the interaction between sex and de-
pression was signiﬁcant (P  0.048). Re-
sults for the association between odds of
diabetes and depression are shown strat-
iﬁed by sex (Table 3). Signiﬁcant interac-
tions were not found between having
separated from service and symptoms of
psychiatric conditions.
The ﬁnal multivariable model in-
cluded the variables shown in Table 3.
Older age or larger BMI, non-Caucasian
ethnicity, having separated from the mil-
Table 2—Relative odds of incident self-reported diabetes by each baseline characteristic of
interest adjusted for age, sex, race/ethnicity, education, and BMI
Baseline characteristic OR (95% CI)* P value
Deployment before 2001 0.5839
No previous deployments 1.00
1991 Gulf War only 0.78 (0.53–1.16)
Bosnia/Kosovo/Southwest Asia only 1.06 (0.82–1.38)
Both contingencies 0.98 (0.62–1.55)
Deployment to OEF/OIF before baseline 0.8744
No 1.00
Yes 0.95 (0.52–1.75)
Deployed to OEF/OIF between baseline and follow-up 0.1444
Nondeployed 1.00
Deployed without combat exposures 0.66 (0.44–1.00)
Deployed with combat exposures 0.99 (0.68–1.42)
Number of deployments between baseline and follow-up 0.2272
0 1.00
1 0.94 (0.66–1.34)
2 0.53 (0.29–0.97)
3 0.90 (0.51–1.59)
Separated from military as of follow-up <0.0001
No 1.00
Yes 1.86 (1.45–2.39)
Branch of service 0.4113
Army 1.00
Navy/Coast Guard 1.16 (0.88–1.52)
Marines 0.97 (0.49–1.93)
Air Force 0.87 (0.66–1.15)
Component 0.9435
Reserve/Guard 1.00
Active duty 0.99 (0.78–1.26)
Alcohol consumption 0.5004
None 1.00
Problem drinking only 0.72 (0.18–2.93)
Binge drinking only 0.83 (0.65–1.06)
Both of the above 0.92 (0.63–1.35)
Smoking status 0.3185
Nonsmoker 1.00
Past smoker 0.87 (0.68–1.11)
Current smoker 1.12 (0.82–1.51)
Depressive disorder 0.0838
No 1.00
Yes 1.54 (0.94–2.50)
Panic disorder 0.0005
No 1.00
Yes 2.88 (1.58–5.24)
Other anxiety disorder 0.0488
No 1.00
Yes 1.77 (1.00–3.13)
PTSD <0.0001
No 1.00
Yes 2.24 (1.54–3.26)
N  44,754. *Bold values indicate statistical signiﬁcance at P  0.05.
Diabetes incidence in the Millennium Cohort
1774 DIABETES CARE, VOLUME 33, NUMBER 8, AUGUST 2010 care.diabetesjournals.orgitary, and PTSD were signiﬁcantly associ-
ated with an increased odds of incident
diabetes. The OR for panic disorder re-
mained elevated but was no longer statis-
tically signiﬁcant. Higher educational
level and being on active duty were asso-
ciated with a lower odds of diabetes. The
interaction between sex and depression
revealed that depressed men and women
didnothaveasigniﬁcantlyhigheroddsof
diabetes compared with nondepressed
men (Table 3). Nondepressed women,
though, had higher odds of diabetes than
nondepressed men.
The Venn diagram displays the co-
occurrence of symptoms of PTSD, de-
pression, and panic in this population
(Fig. 1). There is moderate overlap of
these conditions. The majority of individ-
uals who met the criteria for symptoms of
depression also were found to have PTSD
symptoms(57%).Asmallerproportionof
individuals with PTSD symptoms had co-
existing symptoms of depression (42%).
CONCLUSIONS— PTSD symptoms
were independently related to the occur-
rence of self-reported diabetes in this
population. All psychiatric conditions
considered were associated with a higher
riskinunadjustedanalyses(Table1).The
association with depression was dimin-
ished in magnitude and no longer statis-
tically signiﬁcant after adjustment for
baseline factors commonly associated
withtype2diabetes(Table2).OnlyPTSD
symptoms remained strongly and signiﬁ-
cantly related to diabetes occurrence in a
multivariable model that considered all
psychiatric conditions and characteristics
of military service (Table 3).
Several features of military service
were also associated with diabetes risk,
including Reserve status and having sep-
arated from the military between baseline
and follow-up. Active-duty service may
be associated with higher energy expen-
diture that would be expected to lower
diabetesrisk.Wecouldnotassessthisfac-
tor directly because we did not measure
physical activity at the baseline survey.
The reasons for the association between
separation from military service and
higherdiabetesriskarealsounknownbut
might plausibly reﬂect medical discharge
due to uncontrolled diabetes, failure to
reenlist due to declining health, or higher
diagnostic intensity associated with the
process of being discharged from military
service.
Deployment without combat expo-
sure was associated with a lower risk of
diabetes in unadjusted analyses com-
paredwithnondeployment,butthisasso-
ciation was only borderline signiﬁcant
after adjustment for known diabetes risk
factors (Table 2). This lower risk is prob-
ably due to the screening process used to
select deployers, an aim of which is to
exclude individuals who do not meet
medical and/or ﬁtness criteria for this as-
signment (10). A 14-year follow-up sur-
veyof1991GulfWareraveteransdidnot
ﬁnd a statistically signiﬁcant difference in
prevalenceofdiabetesassociatedwithde-
ployment in this conﬂict (11).
Research on the biological correlates
of PTSD and diabetes revealed some in-
triguing similarities and differences.
Commonﬁndingsincludehigherlevelsof
inﬂammatory markers and endothelial
dysfunction (12,13). Neuroanatomical
similarities have been reported, with
lower hippocampal volumes demon-
strated in relation to PTSD and diabetes
(14,15). The hippocampus plays an im-
portant role in learning and memory and
may also regulate food intake (16).
Whether these brain-imaging ﬁndings
precede or follow the development of di-
abetes and PTSD is not known. Abnor-
malities of the hypothalamic-pituitary-
adrenal axis have been reported in both
pre-diabetes and diabetes, as demon-
stratedbyexcesscortisolproduction(17).
Bjo ¨rntorp et al. (17) proposed that stress-
ful experiences activate the hypothalam-
ic-pituitary axis, leading to excessive
cortisol production, central body fat dis-
tribution, insulin resistance, and associ-
ated metabolic abnormalities. Some but
not all investigations of cortisol produc-
tion in individuals with PTSD, though,
have reported paradoxically low cortisol
levels compared with those in control
subjects (18). Individuals with PTSD fre-
Table 3—Adjusted relative odds of incident self-reported diabetes
Baseline characteristic* OR (95% CI)† P value
Age in years at baseline submission 1.06 (1.05–1.08) <0.001
BMI 1.20 (1.17–1.23) <0.001
Race/ethnicity 0.016
Caucasian 1.00
African American 1.46 (1.10–1.94)
Hispanic 1.35 (0.89–2.05)
Asian 1.67 (1.11–2.52)
Other 1.07 (0.52–2.19)
Education 0.005
No high school diploma 1.00
High school diploma or equivalent 1.26 (0.77–2.06)
Some college 1.28 (0.78–2.11)
Bachelor’s degree 0.84 (0.49–1.43)
Master’s/postdoctoral degree 0.65 (0.36–1.19)
Separated from military as of follow-up 0.001
No 1.00
Yes 2.18 (1.61–2.93)
Component 0.034
Reserve/Guard 1.00
Active duty 0.74 (0.56–0.98)
Panic disorder 0.067
No 1.00
Yes 1.86 (0.96–3.60)
PTSD 0.002
No 1.00
Yes 2.07 (1.31–3.29)
Depression and sex interaction
Nondepressed men 1.00
Depressed men 1.14 (0.60–2.15) 0.695
Nondepressed women 1.63 (1.26–2.13) 0.001
Depressed women 0.51 (0.15–1.70) 0.273
N  44,754. *The multivariable model has been adjusted for each baseline characteristic listed in the table
and also military occupation as shown in the supplementary Tables 1–3, available in an online appendix at
http://care.diabetesjournals.org/cgi/content/full/dc10-0296/DC1. †Bold values indicate statistical signiﬁ-
cance at P  0.05.
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sleep duration, both of which have been
foundtoberiskfactorsfortype2diabetes
(19,20). We could not address this issue
directly because the survey did not in-
clude questions speciﬁcally designed to
address sleep quality or duration.
In contrast to our ﬁndings, a meta-
analysis of multiple observational studies
has reported a higher risk of diabetes as-
sociated with depression (2). In common
with PTSD, depression is associated with
hippocampal atrophy and sleep disorders
but differs in that higher cortisol produc-
tion is often observed (21,22). No signif-
icant association between depression and
the new onset of diabetes was seen after
adjustment for covariates, suggesting that
the depression-diabetes association in
this cohort can be explained by other
known risk factors. A likely explanatory
variable is being overweight, a major dia-
betes risk factor and more common in
those with depression. In addition, the
high co-occurrence of PTSD and depres-
sion in this population may indicate that
in other studies not directly measuring
both of these conditions, depression may
serve as a surrogate marker for PTSD and
possibly not be otherwise independently
associated with diabetes. To our knowl-
edge, no prior study of depression and
diabetes has adjusted for the presence of
PTSD. Furthermore, although our sub-
jects were younger than those included in
severalpreviousstudiesofdepressionand
diabetes, it does not seem that this age
difference can explain the absence of an
association, because studies have re-
ported that the risk of diabetes associated
withdepressionwashigherinindividuals
younger than age 50 years (23).
A signiﬁcant interaction between sex
and depression was observed: nonde-
pressed women were at signiﬁcantly
higherriskofdiabetesthannondepressed
men, whereas the risk in depressed
women was not increased. We are not
aware of a plausible explanation for this
ﬁnding, and further research will be
needed to determine whether this is a
chance association.
There are several limitations to this
study. Self-reported diabetes status was
used without direct testing or medical
record conﬁrmation. A review of the va-
lidity of self-reported diabetes based on
survey data compared with clinical as-
sessment or review of medical encounter
data demonstrated sensitivities ranging
from 70 to 99% (median 81%) and spec-
iﬁcitiesfrom92to99%in11studies(24).
Therefore, it is likely that we captured
considerably more than half of the cases
of diabetes at both baseline and follow-
up; there is a low probability of falsely
classiﬁed cases given the high speciﬁcity
of self-report. The 36% participation rate
at baseline could potentially have led to
biasonlyifnonparticipationwaslinkedto
both mental health conditions and higher
(orlower)futurediabetesrisk.Losstofol-
low-up (28.6%) is a potential source of
bias if an association existed between the
likelihood of being lost to follow-up and
boththeoutcomeandexposure.Theﬁlter
used to determine deployment eligibility
resulted in apparently healthier individu-
als receiving this assignment, as reﬂected
by the lower risk of diabetes in this group
in unadjusted analyses. Whether our ad-
justed models adequately accounted for
this confounding is uncertain. Mental
health conditions were assessed using
self-reportedsurveydatathatpresumably
representcliniciandiagnosisbutwerenot
validated here. The deﬁnitions of mental
health conditions were based on estab-
lished survey methods that have high lev-
els of sensitivity and speciﬁcity. The
PCL-C has been shown to have high dis-
crimination with an area under the re-
ceiver operating characteristic curve of
0.88 compared with the gold standard
Clinician-Administered PTSD Scale (25).
We cannot eliminate the possibility that
subjects underreported mental health
symptoms because of concern of adverse
consequences regarding their service
record. To ease this concern, we did not
involvelocalcommandinthedistribution
or processing of surveys and provided as-
surances of conﬁdentiality in the consent
form that the information provided
would be used for research purposes
only. We did not account for use of psy-
choactive medications in this cohort, sev-
eral of which have been reported to be
associated with a higher risk of diabetes
(26), and we cannot exclude the possibil-
ity that medications prescribed for treat-
ment of PTSD symptoms led to diabetes.
However, we did ask the following gen-
eral question at baseline about the use of
these medications: “Are you currently
taking any medication for anxiety, de-
pression, or stress?” Of individuals meet-
ing criteria for PTSD, 21.4% responded
afﬁrmativelytothisquestion.Thislowex-
posure to psychoactive pharmaceuticals
argues against use of these medications
potentially explaining the observed asso-
ciation between PTSD and diabetes risk.
The potential exists for diabetes detection
bias in individuals under medical treat-
ment for PTSD. Because we did not iden-
tifyPTSDthroughmedicalencountersthe
likelihood of this bias should not be high.
It is not clear whether PTSD symptoms
reported at baseline were the result of ex-
Figure 1—Co-occurrence of PTSD, panic, and depression among subjects at baseline.
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itary service or during civilian life.
Because development of type 1 diabetes
results in medical discharge from military
service, we believe that we were able to
identify all such individuals and exclude
them from this analysis.
In summary, we found that symp-
toms of PTSD but not depression were
independently associated with an in-
creased risk of diabetes in military service
members. To our knowledge this is the
ﬁrst report of a prospective association
between PTSD and diabetes, and conﬁr-
mation by additional research is needed.
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